AeroLeads people directory · profile
Nancy Martin Email & Phone Number
Co-Founder, Chief Medical Officer
at
BlueChain Bio
1 work email found
@bluechainbiotx.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 86%
Current company
Role
Co-Founder, Chief Medical Officer
Location
Greater Chicago Area, United States, United States
Company size
Who is Nancy Martin? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Nancy Martin is listed as Co-Founder, Chief Medical Officer at BlueChain Bio, a company with 3 employees, based in Greater Chicago Area, United States, United States. AeroLeads shows a work email signal at bluechainbiotx.com and a matched LinkedIn profile for Nancy Martin.
Nancy Martin previously worked as Managing Director at Clinically Meaningful, Llc and Chief Medical Officer, Executive Vice President R&D at Tersera Therapeutics. Nancy Martin holds Doctor Of Medicine - Md from Rutgers Robert Wood Johnson Medical School.
Company email context
Email format at BlueChain Bio
This section adds company-level context without repeating Nancy Martin's masked contact details.
{first}.{last}@bluechainbiotx.com
89% confidence
AeroLeads found 1 current-domain work email signal for Nancy Martin. Compare company email patterns before reaching out.
Profile bio
About Nancy Martin
Dr. Nancy Martin is an experienced pharmaceutical R&D executive with over 25 years of value-added impact to patients. She is a strategic leader and independent thinker with a flexible approach to deliver results. She has broad and deep experience in clinical practice and the pharmaceutical industry. Nancy is regarded as a trusted advisor to multidisciplinary teams in dynamic environments in small, mid-size and large organizations. Having worked in a multitude of therapeutic areas in various roles across disciplines including clinical pharmacology & biopharmaceutics, preclinical development, clinical development, medical science and medical affairs in all phases of drug and/or device development, Nancy is driven by the promise of bring new therapies to patients. Nancy has lead teams through strategic negotiations with various health authorities including numerous successful global submissions, product defenses, successful FDA Advisory Committees/ EU Oral Explanations and first-cycle approvals of new drugs, biologics, generics, biosimilars, devices, and combination products. She is currently leading her team at Astellas to advance cellular and gene therapies as part of the diversified portfolio of transformative therapeutics across medical specialties. She is a catalyst for cross-functional teams in their strategic delivery to key milestones for high profile development portfolio decisions. Nancy is trained as a physician and pharmacist. Her career began as a clinical pharmacologist at Hoffmann-La Roche. Throughout her career, Nancy held roles of increasing responsibility at Roche, Aventis, Hospira, Pfizer, Baxter and Astellas across multiple disciplines in research, development and medical affairs. She served as Chief Medical Officer of Outpost Medicine, a Frazier Portfolio Company with focus in women’s health and as Chief Medical Officer of TerSera Therapeutics, a GTCR Portfolio Company, with focus in oncology and rare disease.Nancy is a keen advocate of professional development for team members as an invested people manager. In addition, Nancy maintains connections as Adjunct Faculty for her alma maters and mentors pharmacy and medicine fellows with career interest in the pharmaceutical industry. Nancy is an author of over 100 scientific abstracts, posters, manuscripts and book chapters and has been an invited speaker at numerous international scientific congresses. She maintains active licenses as a registered pharmacist and as a physician to practice medicine in multiple jurisdictions.
Current workplace
Nancy Martin's current company
Company context helps verify the profile and gives searchers a useful next step.
Bluechain Bio
13 roles
Nancy Martin work experience
A career timeline built from the work history available for this profile.
Managing Director
Current
Clinically Meaningful, Llc
Clinically meaningful started out in 2017, where I provided consultation services to Pfizer including a successful delivery of a positive FDA Oncologic Drugs Advisory Committee Vote for the first US Epoetin Biosimilar (May 25, 2017). Served as the primary presenter and defended the nonclinical and clinical data package in support of a positive benefit/risk.
Jul 2016 - Present
Chief Medical Officer, Executive Vice President R&D
Reporting to the Chief Executive Officer, I served in an executive leadership capacity as a management partner leading the strategic and operational excellence of the medical affairs, clinical development, pharmacovigilance and regulatory affairs disciplines of TerSera Therapeutics.
May 2022 - Aug 2024
Vice President, Global Medical Science Head, Medical Specialties
Reporting to the Senior Vice President, Development Therapeutic Areas, I serve in an executive leadership capacity to drive medical strategic direction for the medical team in Medical Specialties, Medical & Development. In this role, I am responsible for overseeing the design and delivery of the medical strategic elements of development programs across a.
Jul 2019 - May 2022
Vice President, Clinical And Preclinical Development
Reporting to the Chief Science and Technology Officer and member of the R&D senior leadership team, I served in an executive capacity to lead a transformation of the clinical and preclinical R&D organization, optimizing development strategy and operational excellence culminating in $10 million savings for the organization while enhancing scientific rigor.
Oct 2017 - May 2019
Senior Vice President, Chief Medical Officer, Outpost Medicine, A Frazier Portfolio Company
Reporting directly to the Chief Executive Officer, I served in an executive capacity leading a global clinical, regulatory, quality and medical affairs organization with focus on women's heath in genitourinary and gastrointestinal conditions. In this role as CMO of a Frazier Portfolio Company, I was accountable to the CEO and Board of Directors for value.
Jul 2016 - Oct 2017
Vice President, Clinical Development Biosimilars
Reporting directly to the Chief Medical Officer, Global Established Products R&D and member of the CMO leadership team, I lead a clinical development organization with focus o the biosimilars portfolio. In this role, I was accountable for a portfolio of multiple biosimilar assets for development strategy, clinical expertise, oversight of clinical.
May 2015 - Jul 2016
Vice President, Global Clinical Development, Hospira, A Pfizer Company
As Vice President, Global Clinical Development at Hospira, A Pfizer Company, I reported directly to the Chief Medical Officer and lead a global cross function clinical development organization comprise of medical development, clinical pharmacology, statistics, data management, and clinical programming supporting all phases of development and life cycle.
May 2013 - May 2015
Senior Medical Director, Astellas Scientific And Medical Affairs
In this role, I lead the Urology Astellas Scientific and Medical Affairs team to ensure launch excellence for Myrbetriq/Betmiga, a first in class, novel therapeutic for overactive bladder. I was accountable for the medical affairs strategic plan for product approval and launch preparation activities for Myrbetriq (mirabegron) and ongoing medical affairs.
Jan 2012 - May 2013
Medical Director, Medical Sciences
I served as Global Medical Lead for Myrbetriq/Betmiga where I was accountable for the medical strategy and delivery of the mirabegron development program to support global registrations, defenses and approvals. In this role, I provided medical leadership to the team which achieved simultaneous submissions in advance of goal for the EU-MAA and US-NDA in.
Oct 2009 - Dec 2012
Associate Medical Director, Medical Sciences
I provided medical leadership for the global Phase 2/3 development program for mirabegron in overactive bladder, delivering a 41 study global clinical development package. I also served as medical lead for various GI programs in Phase 2 development in this role.
Oct 2008 - Oct 2009
Clinical Pharmacokineticist, Global Biopharmaceutics At Aventis, Inc
In this role, I was responsible for driving DMPK interdepartmental drug development programs (Ph 1-3) for new chemical entities (M100240, carioride, exubera) through the use of multidisciplinary matrix teams. I was responsible for the development and implementation of clinical pharmacology programs in support of NDA/MAA submissions including strategy and.
Aug 2000 - Aug 2003
Clinical Pharmacologist
In this role, I implemented the clinical pharmacology/clinical pharmacokinetic program including authorship of the clinical pharmacology sections of the NDA/MAA submission for PEGASYS (pegylated interferon alfa-2a). I served as the lead clinical pharmacologist for product labeling for this product. In addition, I was a major contributor to the clinical.
Jul 1997 - Jul 2000
6 education records
Nancy Martin education
Doctor Of Medicine - Md
Rutgers Robert Wood Johnson Medical School
Doctor Of Pharmacy - Pharmd
University Of Illinois Chicago
Residency In Ophthalmology
Northwestern University - The Feinberg School Of Medicine
Internship/Residency, Department Of Internal Medicine At Memorial Sloan Kettering Cancer Center, Internal Medicine
Cornell University
Post Doctoral Fellowship In Clinical Pharmacology
Rutgers University
Pre-Pharmacy Curriculum
University Of Missouri-Kansas City
FAQ
Frequently asked questions about Nancy Martin
Quick answers generated from the profile data available on this page.
What company does Nancy Martin work for?
Nancy Martin works for BlueChain Bio.
What is Nancy Martin's role at BlueChain Bio?
Nancy Martin is listed as Co-Founder, Chief Medical Officer at BlueChain Bio.
What is Nancy Martin's email address?
AeroLeads has found 1 work email signal at @bluechainbiotx.com for Nancy Martin at BlueChain Bio.
Where is Nancy Martin based?
Nancy Martin is based in Greater Chicago Area, United States, United States while working with BlueChain Bio.
What companies has Nancy Martin worked for?
Nancy Martin has worked for Bluechain Bio, Clinically Meaningful, Llc, Tersera Therapeutics, Astellas Pharma, and Baxter International Inc..
How can I contact Nancy Martin?
You can use AeroLeads to view verified contact signals for Nancy Martin at BlueChain Bio, including work email, phone, and LinkedIn data when available.
What schools did Nancy Martin attend?
Nancy Martin holds Doctor Of Medicine - Md from Rutgers Robert Wood Johnson Medical School.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial